About the Opportunity

This opportunity is focused on a clinically validated hemodynamic monitoring platform designed to non-invasively estimate pulmonary capillary wedge pressure and right atrial pressure at the bedside in under five minutes.

The platform has received FDA Breakthrough Device designation and has demonstrated strong clinical performance across multiple international studies and hospital systems.

Clinical highlights include:

CAPTURE-HF study involving 1,600 patients across 20 hospitals in 6 countries

AUC 0.852 for right atrial pressure (RAP)

AUC 0.821 for pulmonary capillary wedge pressure (PCWP)

Recognition as ACC Non-Invasive Monitoring Technology of the Year

Enrollment underway for a 1,000-patient HOSP-HF pivotal study

FDA clearance target scheduled for mid-2027

The company has secured $4.5 million of its current $7 million seed extension round.

What the Company Needs

The organization is seeking experienced medtech operators who have experience navigating the transition between late-stage clinical validation and commercial scale.

The focus is on individuals with hands-on experience in areas such as:

FDA 510(k) submission and clearance strategy

CE marking and international regulatory sequencing

Hospital capital sales or point-of-care device commercialization

Health economic evidence generation and reimbursement strategy

Business development, licensing, or strategic transactions within medtech

Candidates with backgrounds from organizations such as Medtronic, Abbott, Philips, GE HealthCare, Edwards, Boston Scientific, or similar companies are strongly preferred.

The Engagement

Time Commitment:
1–2 hours per month

The advisory engagement will focus on topics including:

510(k) sequencing strategy

Health economics positioning

Hospital sales strategy

Commercial fundraising preparation

Strategic transaction positioning for 2027–2028

Engagement structure includes:

Calls

Asynchronous strategic input

Industry introductions where relevant

Compensation

Equity-based compensation only

Founding advisory position with potential long-term equity upside

Limited allocation available within the company’s current seed financing round alongside institutional investors including Bayer, Cedars-Sinai, and the European Innovation Council

Candidate Profile

10+ years of experience in medtech commercialization, regulatory strategy, or business development

Direct experience with FDA, CMS, or CE regulatory frameworks

Track record bringing capital equipment or point-of-care diagnostics to market

Comfortable operating at the strategic advisory level rather than day-to-day execution

Additional Information

This is positioned as a founding advisory opportunity rather than a traditional operational role or salaried position.

‍